This year’s symposium is themed “Driving translation with transformative science.” Invited speakers and Medicine by Design principal investigators will focus on telling strong translational stories, starting with leading edge science and enabling technologies through to commercialization and patient impact.
Since 2016, Medicine by Design has married high risk, high reward research, with a strategy for accelerating the translation of emerging innovations toward new regenerative medicine products and companies.
